This two-day event will feature presentations and interactive discussions about the issue of biospecimen quality and ways to address it. The symposium addresses the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine.
Hosted by NCI's Office of Biorepositories and Biospecimen Research, the meeting brings together leaders in the fields of biospecimen research, genomics, proteomics, oncology, pathology, biobanking, hospital administration and pharmaceutics as well as patient advocates.
This year's featured topics:
• Developing metrics for biospecimen quality
• Biospecimen Science and Molecular Diagnostics
• Assessing the effects of biospecimen preanalytical variables on mRNA, miRNA,
• Collection of high quality, well annotated normal tissues for molecular research
• Tools for accessing published data in biospecimen science
• Empowering community pathologists to improve biospecimen quality
Speakers will include:
• George Poste, Chief Scientist, Complex Adaptive Systems Initiative and Professor of Health Innovation, Arizona State University
• Thomas Malone, Vice President, Transformation, College of American Pathologists
• Carolyn Compton, Director, Office of Biorepositories and Biospecimen Research,
National Cancer Institute
• Jennifer Hunt, Associate Pathologist and Associate Chief for Quality and Safety,
Massachusetts General Hospital; Associate Professor of Pathology, Harvard Medical School